T-Wave Inversions Were Found in 4% of Athletes in 258,954-Person Review

A systematic review has pooled 115 studies and 258,954 people to estimate how often t-wave inversions appear on athlete electrocardiograms. The pooled figure was about 4% in athletes older than 16, and the prognosis attached to those t-wave inversions remains unsettled.

T-wave inversions sit at an uncomfortable crossroads in sports medicine. They can be a harmless signature of a heart that has adapted to years of training, or the earliest visible hint of a cardiomyopathy that has not yet declared itself. A systematic review and meta-analysis published in Sports Medicine – Open on October 2, 2026 set out to put defensible numbers on both possibilities.

The review was led by Javier Sanmartin with Roberto Elosua of the Hospital del Mar Research Institute in Barcelona as corresponding author, alongside Joan Cartanya-Bonvehi, Helen Valenzuela, Lidia Carballeira, Silvia Montserrat and Adrian Baranchuk. The team searched PubMed, Scopus and Web of Science through September 2023, updated the searches through June 2025, followed PRISMA guidelines, and registered the protocol in PROSPERO under CRD42023494038.

Of 4,509 articles identified, 115 were selected, together covering 258,954 individuals. Applied to athletes older than 16 under the International criteria, the global prevalence of t-wave inversions was 4%, which the authors broke down by lead territory as 3% in anterior leads, 1% in inferior leads and 0% in lateral leads.

Athletes carried the pattern more often than people who do not train. The pooled prevalence ratio was 1.49, with a 95% confidence interval of 1.13 to 1.97. Even so, cardiomyopathy was diagnosed in fewer than 1% of athletes with t-wave inversions in most of the included studies, and the incidence of acute cardiovascular events was low, with heterogeneity the authors describe as high.

What the Criteria Count as T-Wave Inversions

Pooling numbers across 115 papers only works if everyone measured the same thing. The review leaned on established thresholds rather than inventing one. As the authors state it, the Seattle and International criteria define TWI as a negative T wave greater than or equal to 1 mm in 2 contiguous leads, excluding leads aVR, II and V1.

Age changed the reading. In athletes 16 or younger, t-wave inversions in V2 or across V2 to V3 were treated as a juvenile pattern and analysed independently. That is why the headline 4% belongs to athletes older than 16 and should not be carried across to a 14-year-old whose electrocardiogram looks similar.

Why the Search Had to Be This Large

The funnel from 4,509 candidate articles to 115 included papers is the quiet story here. Prevalence of an electrocardiographic finding depends on who was screened, which criteria were applied, and in which decade. Smaller single-cohort reports have produced numbers that scatter widely, which is exactly the problem a pooled estimate is built to address.

The 258,954 individuals in the final set span sports, sexes and races, because the inclusion rule accepted original research on athletes participating in any type of sport, of any sex or race. Breadth of that kind is what allows a 4% estimate to carry weight, and it is also what imports the heterogeneity the authors keep flagging.

Where on the Tracing the Pattern Clusters

Lead territory is not a technicality. The 3% figure in anterior leads, 1% in inferior leads and 0% in lateral leads tracks the clinical hierarchy that sports cardiologists already use: anterior changes in a young athlete are often reconciled with normal physiology, while lateral changes have historically been the ones that prompt a harder look.

That the pooled lateral figure rounded to 0% is itself informative. Lateral t-wave inversions are rare enough in screened athlete populations that any individual case deserves evaluation rather than reassurance by base rate.

Athletes Versus Non-Athletes

The prevalence ratio of 1.49 (95% CI 1.13 to 1.97) says the pattern is roughly half again as common in athletes as in people who do not train. The interval excludes 1, so the direction is reasonably firm, though its width shows how much room remains around the size of the gap.

A plausible reading is ventricular remodelling. Sustained training reshapes the heart, and the authors note that t-wave inversions may reflect physiological exercise related ventricular remodelling. The same logic has shown up in imaging work on physiological cardiac remodeling in elite weightlifters, where structural change was read as adaptation rather than disease.

Prevalence Was Higher in Black Athletes

The review reports that prevalence was higher in Black athletes. That finding is not new to sports cardiology, and it is the reason modern screening criteria treat anterior t-wave inversions in Black athletes differently from the same tracing in a white athlete. The practical consequence is that a single universal threshold would generate avoidable false alarms in some populations and risk complacency in others.

What the review does not supply is a clean head-to-head percentage between racial groups, so the direction of the difference is better supported than its magnitude.

How Often T-Wave Inversions Signalled Disease

This is the question athletes actually ask, and it is where the evidence thins. Cardiomyopathy diagnosis among athletes with t-wave inversions showed high variability, but in most studies prevalence was under 1%. Acute cardiovascular event incidence was low in most of the studies, again with high heterogeneity.

Low and uncertain are not the same claim. The authors are explicit that the risk of cardiovascular events is uncertain due to low statistical power and high heterogeneity, which means the reassuring numbers describe what was observed rather than settling what the long-run risk is.

What the Finding Does and Does Not Mean for Readers

For anyone who trains seriously and has been handed an electrocardiogram with an unexpected comment on it, the review offers context rather than an answer. It says the pattern is more common in athletes than non-athletes, that it is still uncommon in absolute terms, and that most athletes who have it are not found to have a cardiomyopathy.

What it does not say is that the finding can be dismissed. The authors conclusion is pointed: while it may reflect physiological exercise related ventricular remodelling, thorough evaluation is essential to exclude structural heart disease. Base rates inform a workup. They do not replace one.

• An electrocardiogram comment is a prompt for evaluation by a clinician, not a diagnosis and not a clearance.
• Age and race change how the same tracing is interpreted, which is why criteria exist and why self-interpretation goes wrong.
• New symptoms during exercise, such as chest discomfort, unexpected breathlessness, fainting or near-fainting, warrant prompt medical attention regardless of what a prior tracing showed.
• A normal tracing is not a performance ceiling, and an abnormal one is not automatically a stop sign; both are inputs to a clinical conversation.

This sits alongside other work on how training reshapes measurable physiology. Studies of lung function measured in marathon runners and of estimated cardiorespiratory fitness and later disease risk make the same general point from different directions: trained bodies read differently on standard tests, and the reference range built on untrained people is not always the right yardstick.

Where This Leaves Screening

Pre-participation screening has always been a trade between catching rare disease and generating anxiety, cost and unnecessary restriction. A pooled 4% prevalence of t-wave inversions gives program designers a number to plan around: in a cohort of 1,000 screened athletes over 16, roughly 40 tracings would be expected to carry the finding, and in most studies fewer than 1% of those athletes went on to a cardiomyopathy diagnosis.

Those two figures together explain why the field keeps refining criteria rather than abandoning screening. They also explain why the authors stop short of a prognostic claim. Evidence on secondary prevention in general, including work on recurrent heart events and lifestyle patterns, has needed far larger prospective samples than anything available here before risk could be estimated with confidence.